Literature DB >> 28441666

A MicroRNA-124 Polymorphism is Associated with Fracture Healing via Modulating BMP6 Expression.

Lin Zou, Guichun Zhang, Lifeng Liu, Chen Chen, Xuecheng Cao, Jinfang Cai.   

Abstract

BACKGROUND: miR-124-3p has been reported to be involved in the pathogenesis of many diseases by modulating a variety of signaling pathways. In this study, we aimed to understand the impact of miR-124-3p expression level on the fracture healing in the patients of metaphyseal fracture of distal tibia, who received minimal invasive percutaneous plate osteosynthesis.
METHODS: We firstly collected 195 patients of metaphyseal fracture of distal tibia, and the genotype of rs531564 was determined: GG (n=124) and GC+CC (n=71). We collected information of the participants including age, gender, total in-hospital time, smoking and alcohol consumption. Subsequently, we searched the miRNA database online to identify the possible binding sequence of miR-124-3p located within the 3'-UTR of the target gene. We did correlation analysis and luciferase to understand the regulatory relationship between miR-124-3p and BMP6. Meanwhile, we also conducted real time PCR and western blotting analysis to study the mRNA and protein expression level of BMP6 in different genotype groups. We then treated the cells with scramble control, miR-124-3p mimics, BMP6 siRNA and miR-124-3p inhibitors to investigate the influence of miR-124-3p on the expression of BMP6, viability and apoptosis of cells.
RESULTS: Total in-hospital time was significantly longer in GC+CC group than GG group. MiR-124-3p was up-regulated in GG group than GC and CC groups. BMP6 was virtual target of miR-124-3p. There existed negative regulatory relationship betweenmiR-124-3p and BMP6. The mRNA and protein expression level of BMP6 decreased in GG group. MiR-124-3p decreased the expression of BMP6. MiR-124-3p negatively interfered with the viability of cells and BMP6 positively interfered with the viability of cells. MiR-124-3p reduced apoptosis and BMP6 promoted apoptosis.
CONCLUSION: These data proved the expression of miR-124-3p was associated with the healing of metaphyseal fracture of distal tibia, and could be recognized as a biomarker to predict the healing of metaphyseal fracture of distal tibia.
© 2017 The Author(s)Published by S. Karger AG, Basel.

Entities:  

Keywords:  Apoptosis; BMP6; Fracture healing; MicroRNA-124; Polymorphism; rs531564

Mesh:

Substances:

Year:  2017        PMID: 28441666     DOI: 10.1159/000475570

Source DB:  PubMed          Journal:  Cell Physiol Biochem        ISSN: 1015-8987


  6 in total

1.  Regulatory role of microRNA-185 in the recovery process after ankle fracture.

Authors:  Deping Sun; Juntao Liu; Qingpeng Shi; Haibo Mu; Dongsheng Zhou
Journal:  Exp Ther Med       Date:  2018-07-27       Impact factor: 2.447

Review 2.  The Therapeutic Potential of MicroRNAs as Orthobiologics for Skeletal Fractures.

Authors:  Michael Hadjiargyrou; David E Komatsu
Journal:  J Bone Miner Res       Date:  2019-03-28       Impact factor: 6.741

3.  Association between polymorphisms in microRNAs and susceptibility to diabetes mellitus: A meta-analysis.

Authors:  Xi Chen; Wenjing Wang; Ruien Li; Jing Yu; Lei Gao
Journal:  Medicine (Baltimore)       Date:  2019-11       Impact factor: 1.817

4.  Long Noncoding RNA Zinc Finger Antisense 1 Affects Glucocorticoid-Induced Osteonecrosis of the Femoral Head by Performing as a ceRNA for MicroRNA-124-3p and Accelerating Transforming Growth Factor Type III Receptor.

Authors:  Xiao Yong Lan; YiPin Xiong; HaiPing Ma; LingFeng Zou; Zhen Yuan; YuHong Xiao
Journal:  Comput Math Methods Med       Date:  2022-07-18       Impact factor: 2.809

5.  Effects of repeated sprints training on fracture risk-associated miRNA.

Authors:  Veronica Sansoni; Silvia Perego; Gianluca Vernillo; Andrea Barbuti; Giampiero Merati; Antonio La Torre; Giuseppe Banfi; Giovanni Lombardi
Journal:  Oncotarget       Date:  2018-04-06

6.  Protective effect and mechanism of microRNA-146a on ankle fracture.

Authors:  Haijun Mao; Guangyue Xu
Journal:  Exp Ther Med       Date:  2020-08-25       Impact factor: 2.447

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.